Literature DB >> 23603611

The dark phase intraocular pressure elevation and retinal ganglion cell degeneration in a rat model of experimental glaucoma.

Jacky M K Kwong1, Nancy Vo, Ann Quan, Michael Nam, Haksu Kyung, Fei Yu, Natik Piri, Joseph Caprioli.   

Abstract

Intraocular pressure (IOP) elevation is considered as a major risk factor causing the progression of vision deterioration in glaucoma. Although it is known that the IOP level changes widely throughout the day and night, how the dark or light phase IOP elevation contributes to retinal ganglion cell (RGC) degeneration is still largely unclear. To examine the profile of IOP, modified laser photocoagulation was applied to the trabecular meshwork of Brown Norway rats and both light and dark phase IOPs were monitored approximately 1-2 times a week. The relationship between IOP elevation and RGC degeneration was investigated while RGC body loss was analyzed with Rbpms immunolabeling on retinal wholemount and axonal injury in the optic nerve was semi-quantified. The baseline awake dark and light IOPs were 30.4 ± 2.7 and 20.2 ± 2.1 mmHg respectively. The average dark IOP was increased to 38.2 ± 3.2 mmHg for five weeks after the laser treatment on 270° trabecular meshwork. However, there was no significant loss of RGC body and axonal injury. After laser treatment on 330° trabecular meshwork, the dark and light IOPs were significantly increased to 43.8 ± 4.6 and 23 ± 3.7 mmHg respectively for 5 weeks. The cumulative dark and light IOP elevations were 277 ± 86 and 113 ± 50 mmHg days respectively while the cumulative total (light and dark) IOP elevation was 213 ± 114 mmHg days. After 5 weeks, regional RGC body loss of 29.5 ± 15.5% and moderate axonal injury were observed. Axonal injury and loss of RGC body had a high correlation with the cumulative total IOP elevation (R(2) = 0.60 and 0.65 respectively). There was an association between the cumulative dark IOP elevation and RGC body loss (R(2) = 0.37) and axonal injury (R(2) = 0.51) whereas the associations between neuronal damages and the cumulative light IOP elevation were weak (for RGC body loss, R(2) = 0.01; for axonal injury, R(2) = 0.26). Simple linear regression model analysis showed statistical significance for the relationships between the total cumulative IOP elevation and RGC body loss (P = 0.009), and axonal injury (P = 0.016). To examine the role of light and dark IOP elevation in RGC body loss and axonal injury, analyses for the association between different light/dark IOP factors and percentage of RGC body loss/axonal injury grading were performed and only the association between the cumulative dark IOP elevation and axonal injury showed statistical significance (P = 0.033). The findings demonstrated that the cumulative total (light and dark) IOP elevation is a risk factor to RGC degeneration in a rat model of experimental glaucoma using modified partial laser photocoagulation at 330° trabecular meshwork. Further investigations are required to understand the role of longer term light and dark phase IOP elevation contributing to the progression of degeneration in different compartments of RGCs.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23603611      PMCID: PMC3752778          DOI: 10.1016/j.exer.2013.04.008

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  18 in total

1.  Twenty-four-hour pattern of intraocular pressure in the aging population.

Authors:  J H Liu; D F Kripke; M D Twa; R E Hoffman; S L Mansberger; K M Rex; C A Girkin; R N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-11       Impact factor: 4.799

2.  Modulation of alpha and beta crystallin expression in rat retinas with ocular hypertension-induced ganglion cell degeneration.

Authors:  Natik Piri; Min Song; Jacky M K Kwong; Joseph Caprioli
Journal:  Brain Res       Date:  2007-02-21       Impact factor: 3.252

3.  Nocturnal elevation of intraocular pressure in young adults.

Authors:  J H Liu; D F Kripke; R E Hoffman; M D Twa; R T Loving; K M Rex; N Gupta; R N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  1998-12       Impact factor: 4.799

Review 4.  Glaucoma: thinking in new ways-a rôle for autonomous axonal self-destruction and other compartmentalised processes?

Authors:  Alan V Whitmore; Richard T Libby; Simon W M John
Journal:  Prog Retin Eye Res       Date:  2005-11       Impact factor: 21.198

5.  Circadian rhythm of intraocular pressure in the rat.

Authors:  C G Moore; E C Johnson; J C Morrison
Journal:  Curr Eye Res       Date:  1996-02       Impact factor: 2.424

6.  A rat model of chronic pressure-induced optic nerve damage.

Authors:  J C Morrison; C G Moore; L M Deppmeier; B G Gold; C K Meshul; E C Johnson
Journal:  Exp Eye Res       Date:  1997-01       Impact factor: 3.467

7.  Retinal ganglion cell protection with geranylgeranylacetone, a heat shock protein inducer, in a rat glaucoma model.

Authors:  Yoko Ishii; Jacky M K Kwong; Joseph Caprioli
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-05       Impact factor: 4.799

8.  Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.

Authors:  Kouros Nouri-Mahdavi; Douglas Hoffman; Anne L Coleman; Gang Liu; Gang Li; Douglas Gaasterland; Joseph Caprioli
Journal:  Ophthalmology       Date:  2004-09       Impact factor: 12.079

9.  Comparison of latanoprost with fixed-combination dorzolamide and timolol in adult patients with elevated intraocular pressure: an eight-week, randomized, open-label, parallel-group, multicenter study in Latin America.

Authors:  Remo Susanna; Remo Sussana; Wang-Pui Sheu
Journal:  Clin Ther       Date:  2004-05       Impact factor: 3.393

10.  Evaluation of intraocular pressure elevation in a modified laser-induced glaucoma rat model.

Authors:  Julia Biermann; Christian van Oterendorp; Christian Stoykow; Cornelia Volz; Thomas Jehle; Daniel Boehringer; Wolf Alexander Lagrèze
Journal:  Exp Eye Res       Date:  2012-09-07       Impact factor: 3.467

View more
  20 in total

1.  Effect of glaucoma medications on 24-hour intraocular pressure-related patterns using a contact lens sensor.

Authors:  Kaweh Mansouri; Felipe A Medeiros; Robert N Weinreb
Journal:  Clin Exp Ophthalmol       Date:  2015-08-16       Impact factor: 4.207

Review 2.  Modeling glaucoma in rats by sclerosing aqueous outflow pathways to elevate intraocular pressure.

Authors:  John C Morrison; William O Cepurna; Elaine C Johnson
Journal:  Exp Eye Res       Date:  2015-05-21       Impact factor: 3.467

3.  Reliability of Tonolab measurements in rats.

Authors:  Li-Fang Liu; Chu-Kai Huang; Ming-Zhi Zhang
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

4.  Optic Nerve Traction During Adduction in Open Angle Glaucoma with Normal versus Elevated Intraocular Pressure.

Authors:  Joseph L Demer; Robert A Clark; Soh Youn Suh; Joann A Giaconi; Kouros Nouri-Mahdavi; Simon K Law; Laura Bonelli; Anne L Coleman; Joseph Caprioli
Journal:  Curr Eye Res       Date:  2019-12-02       Impact factor: 2.424

Review 5.  Stem Cells in the Trabecular Meshwork for Regulating Intraocular Pressure.

Authors:  Hongmin Yun; Yi Zhou; Andrew Wills; Yiqin Du
Journal:  J Ocul Pharmacol Ther       Date:  2016-05-16       Impact factor: 2.671

6.  Bilaminar Structure of the Human Optic Nerve Sheath.

Authors:  Alan Le; Andrew Shin; Joseph Park; Vadims Poukens; Joseph L Demer
Journal:  Curr Eye Res       Date:  2020-03-16       Impact factor: 2.424

7.  The pro-inflammatory role of high-mobility group box 1 protein (HMGB-1) in photoreceptors and retinal explants exposed to elevated pressure.

Authors:  Michael R R Böhm; Maurice Schallenberg; Katrin Brockhaus; Harutyun Melkonyan; Solon Thanos
Journal:  Lab Invest       Date:  2016-01-18       Impact factor: 5.662

8.  Induction of significant intraocular pressure diurnal fluctuation in rats using a modified technique of microbead occlusion.

Authors:  Lin Fu; Jimmy Shiu Ming Lai; Amy Cheuk Yin Lo; Kendrick Co Shih
Journal:  Int J Ophthalmol       Date:  2018-07-18       Impact factor: 1.779

9.  Trabecular Meshwork Regeneration - A Potential Treatment for Glaucoma.

Authors:  Alexander Castro; Yiqin Du
Journal:  Curr Ophthalmol Rep       Date:  2019-04-16

10.  Using retinal function to define ischemic exclusion criteria for animal models of glaucoma.

Authors:  Bailey G Hannon; Andrew J Feola; Brandon G Gerberich; A Thomas Read; Mark R Prausnitz; C Ross Ethier; Machelle T Pardue
Journal:  Exp Eye Res       Date:  2020-11-07       Impact factor: 3.770

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.